Expression of the high molecular weight fibroblast growth factor-2 isoform of 210 amino acids is associated with modulation of protein kinases C δ and ε and ERK activation

被引:25
作者
Gaubert, F
Escaffit, F
Bertrand, C
Korc, M
Pradayrol, L
Clemente, F
Estival, A
机构
[1] CHU Rangueil, INSERM U531, ILB, F-31054 Toulouse, France
[2] Univ Calif Irvine, Div Endocrinol Diabet & Metab, Irvine, CA 92697 USA
关键词
D O I
10.1074/jbc.M001184200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The high molecular weight (HMW) fibroblast growth factor (FGF)-2 isoform of 210 amino acids initiated at a CUG start codon possesses a nuclear localization sequence and is not secreted, In contrast, the low molecular weight (LMW) isoform of 155 amino acids initiated at the AUG start codon can be secreted and activates the cell surface FGF receptors, The two isoforms possess different biological properties; however, little is known about the intracrine regulatory mechanisms involved in the biological effects of the HMW FGF-2 isoform, Using pancreatic cells stably transfected with cDNAs leading to the expression of either the HMW FGF-2 (A3 cells) or the LMW form (A5 cells), we provide evidence that the two FGF-2 isoforms differentially modulate PKC levels. The LMW FGF-2 up-regulated the PKC epsilon levels by 1.6-fold; by contrast the HMW isoform down-regulated the level of this PKC isotype by about 3-fold and increased the amount of PKC delta by 1.7-fold. PKC mRNAs were also modified, suggesting that PKC expression was regulated at a pretranslational level. Additionally, expression of different levels of the HMW FGF-2 with an inducible expression system confirmed the role of this isoform on PKC delta and epsilon expressions. Increased activation of ERK-1 and -2 was also observed in cells expressing the HMW FGF-2, By using different PKC inhibitors and a dominant negative PKC delta, it was found that ERK activation was PKC delta -dependent. These data indicate that expression of HMW FGF-2 can modify PKC levels by acting at the intracellular level and that the overexpression of PKC delta induces ERK-1/2 activation. The expression of a dominant negative FGFR1 did not reduce ERK-1/2 activation by the HMW FGF-2, suggesting that ERK activation does not require FGFR activity. The signaling cascade downstream of ERK might be involved in the known mitogenic effect exerted by this FGF-2 isoform.
引用
收藏
页码:1545 / 1554
页数:10
相关论文
共 54 条
[1]  
Arnaud E, 1999, MOL CELL BIOL, V19, P505
[2]   TRANSLOCATION OF BFGF TO THE NUCLEUS IS G1 PHASE CELL-CYCLE SPECIFIC IN BOVINE AORTIC ENDOTHELIAL-CELLS [J].
BALDIN, V ;
ROMAN, AM ;
BOSCBIERNE, I ;
AMALRIC, F ;
BOUCHE, G .
EMBO JOURNAL, 1990, 9 (05) :1511-1517
[3]   THE FGF FAMILY OF GROWTH-FACTORS AND ONCOGENES [J].
BASILICO, C ;
MOSCATELLI, D .
ADVANCES IN CANCER RESEARCH, 1992, 59 :115-165
[4]   DIFFERENTIAL MODULATION OF CELL PHENOTYPE BY DIFFERENT MOLECULAR-WEIGHT FORMS OF BASIC FIBROBLAST GROWTH-FACTOR - POSSIBLE INTRACELLULAR SIGNALING BY THE HIGH-MOLECULAR-WEIGHT FORMS [J].
BIKFALVI, A ;
KLEIN, S ;
PINTUCCI, G ;
QUARTO, N ;
MIGNATTI, P ;
RIFKIN, DB .
JOURNAL OF CELL BIOLOGY, 1995, 129 (01) :233-243
[5]   INTERACTION OF VASCULOTROPIN VASCULAR ENDOTHELIAL-CELL GROWTH-FACTOR WITH HUMAN UMBILICAL VEIN ENDOTHELIAL-CELLS - BINDING, INTERNALIZATION, DEGRADATION, AND BIOLOGICAL EFFECTS [J].
BIKFALVI, A ;
SAUZEAU, C ;
MOUKADIRI, H ;
MACLOUF, J ;
BUSSO, N ;
BRYCKAERT, M ;
PLOUET, J ;
TOBELEM, G .
JOURNAL OF CELLULAR PHYSIOLOGY, 1991, 149 (01) :50-59
[6]   Biological roles of fibroblast growth factor-2 [J].
Bikfalvi, A ;
Klein, S ;
Pintucci, G ;
Rifkin, DB .
ENDOCRINE REVIEWS, 1997, 18 (01) :26-45
[7]  
BORNER C, 1992, J BIOL CHEM, V267, P12892
[8]  
Brodie C, 1999, CELL GROWTH DIFFER, V10, P183
[9]   ALTERNATIVE INITIATION OF TRANSLATION DETERMINES CYTOPLASMIC OR NUCLEAR-LOCALIZATION OF BASIC FIBROBLAST GROWTH-FACTOR [J].
BUGLER, B ;
AMALRIC, F ;
PRATS, H .
MOLECULAR AND CELLULAR BIOLOGY, 1991, 11 (01) :573-577
[10]   ISOLATION OF BIOLOGICALLY-ACTIVE RIBONUCLEIC-ACID FROM SOURCES ENRICHED IN RIBONUCLEASE [J].
CHIRGWIN, JM ;
PRZYBYLA, AE ;
MACDONALD, RJ ;
RUTTER, WJ .
BIOCHEMISTRY, 1979, 18 (24) :5294-5299